Advanced Wound Care Program

About Ionic Pharmaceuticals

Ionic Pharmaceuticals is a private, preclinical-stage biotech developing a novel nanoparticle drug delivery platform with a claimed 50x improvement in tumor accumulation efficiency. The company, a Boston University spin-out, is applying its materials science expertise across two initial sectors: oncology drug delivery and wound care. Led by a team with prior drug development and commercialization success, including a co-inventor of the blockbuster drug Abraxane, Ionic is currently funded by NIH grants and awards as it works towards commercialization.

Therapeutic Areas